NigelSKeyMD

Professor, Medicine, University of North Carolina at Chapel Hill School of Medicine

Dr. Key is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
116 Manning Drive
CB #7036
Chapel Hill, NC 27599
Phone+1 919-966-3311

Dr. Nigel Key is a hematologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from University of Manchester Faculty of Medicine and has been in practice 36 years. He is experienced in thrombotic disorders, general / benign hematology, and transfusion medicine.

PubMed

Research Letter: Patient Attitudes Towards Haemophilia Gene Therapy at a US Haemophilia Treatment Center.
Callie Berkowitz, Kristy Lee, Kristi Kirkland, Brenda Nielsen, Patrick Ellsworth
Haemophilia. 2024-12-24
1 citations
Acquired hemophilia A: a narrative review and management approach in the emicizumab era.
Patrick Ellsworth, Sheh-Li Chen, Lee Ann Jones, Alice D Ma, Nigel S Key
Journal of Thrombosis and Haemostasis. 2024-11-12
Efficacy, safety, and quality of life 4 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A in the phase 3 GENEr8-1 trial.
Andrew D Leavitt, Johnny Mahlangu, Priyanka Raheja, Emily Symington, Doris V Quon
Research and Practice in Thrombosis and Haemostasis. 2024-11-01

Newsworthy from the School of Medicine, Week of July 22 – July 28July 27th, 2022
Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
Data from Spain Yield New Insights on a Rare HemophiliaNovember 2nd, 2021
Join now to see all

Mechanisms Of Venous Thromboembolism In CancerNational Heart, Lung, And Blood Institute2008–2012
Research Fellowships In Hematology/OncologyNational Heart, Lung, And Blood Institute2005–2011
Rituximab For The Treatment Of Inhibitors In Congenital Hemophilia ANational Center For Research Resources2008
PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2004
Catheter Directed Thrombolytic Therapy In Deep Vein ThrombosisNational Center For Research Resources2004
New Therapies For HemophiliaNational Heart, Lung, And Blood Institute2000–2004
Tissue Factor In HemophiliaNational Heart, Lung, And Blood Institute2000–2002
PREVENT: Prevention Of Recurrent Venous ThromboembolismNational Center For Research Resources2000–2002
Endothelial Cells In HomocystinuriaNational Center For Research Resources2000–2002
Mechanisms Of Thrombosis In Sickle DiseaseNational Heart, Lung, And Blood Institute1995–1998
The Role Of The Neutrophil In Inflammatory ThrombosisNational Heart, Lung, And Blood Institute1990–1991